Volume 12, Issue 3 (11-2024)
J Surg Trauma 2024, 12(3): 101-105 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Samidoust P, Attarchi M, Asghari M, Atrkar Z. Prevalence of COVID-19 and Following Personal Protective Protocols among Liver Transplant Candidates and Recipients and their Family Members. J Surg Trauma 2024; 12 (3) :101-105
URL: http://jsurgery.bums.ac.ir/article-1-440-en.html
URL: http://jsurgery.bums.ac.ir/article-1-440-en.html
Department of Surgery, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
Abstract: (371 Views)
Introduction: Person-to-person transmission of COVID-19 disease is reported to be the main route of transmission among the population putting organ transplant candidates and recipients at a high risk of morbidity and mortality. The present study aimed to assess the frequency of following COVID-19 personal protective protocols among liver transplant candidates and recipients.
Methods: In this cross-sectional study, 170 liver transplant candidates and recipients, as well as their family members (n=348), at Guilan transplant center in Rasht, Iran, were selected via convenience sampling method. The participants’ clinical and demographical data, as well as history of COVID-19 infection and adherence to personal protective protocols (mask usage, glove usage, and social and physical distancing), were recorded. Data analysis was performed using SPSS software (version 22).
Results: Out of 170 participants, 84 (49.4%) cases were liver transplant candidates, and 86 (51.6%) subjects were liver transplant recipients. The mean age of liver transplant candidates was 50.24±12.83 years, while the mean age of liver transplant recipients was 42.97±16.56 years. The frequency of COVID-19 infection among liver transplant candidates, liver transplant recipients, family members of liver transplant candidates, and family members of liver transplant recipients were 3(3.6%), 5(5.8%), 4(2.4%), and 2(1.1%), respectively. Patients and their family members' adherence to personal protective protocols was above 90%.
Conclusion: The obtained results pointed to the low frequency of SARS-CoV-2 infection among liver transplant candidates and recipients. The findings highlighted the considerable impact of following personal protective protocols on the prevention of COVID-19.
Type of Study: Research |
Subject:
General
Received: 2024/06/21 | Accepted: 2024/12/10 | ePublished ahead of print: 2024/12/30 | Published: 2025/01/4
Received: 2024/06/21 | Accepted: 2024/12/10 | ePublished ahead of print: 2024/12/30 | Published: 2025/01/4
References
1. Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci. 2021;26:82. [DOI:10.4103/jrms.JRMS_506_20]
2. Faraji N, Zeinali T, Joukar F, Aleali MS, Eslami N, Shenagari M, et al. Mutational Dynamics of SARS-CoV-2: Impact on Future COVID-19 Vaccine Strategies. Heliyon. 2024;10(9). [DOI:10.1016/j.heliyon.2024.e30208]
3. Zeinali T, Faraji N, Joukar F, Maroufizadeh S, Shenagari M, Naghipour M, et al. association between cycle threshold (ct) and clinical outcomes in patients with covid-19. Stud Med Sci. 2023;34(7):397-407. [DOI:10.61186/umj.34.7.397]
4. Zeinali T, Faraji N, Joukar F, Khan Mirzaei M, Kafshdar Jalali H, Shenagari M, et al. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm. Microb Pathog. 2022;170:105704. [DOI:10.1016/j.micpath.2022.105704]
5. Yaghubi T, Shakoori V, Nasiri S, Keivan M, Tavakol C, Ahanjide S, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of cardiovascular disease. J Curr Biomed Reports. 2022;3(1):1-7. [DOI:10.52547/jcbior.3.1.36]
6. Haghighi M, Khoshrang H, Rimaz S, Kalurazi TY, Atrkar Z, Roushan SGT, et al. Evaluation of sequential organ failure assessment (SOFA) score efficiency in predicting the mortality of intensive care unit admitted COVID-19 patients. J Curr Biomed Reports. 2021;2(4):168-175. [DOI:10.52547/JCBioR.2.4.168]
7. Kalurazi TY, Shakoori V, Nasiri S, Foumani AA, Hesni E, Mahfoozi L, et al. Clinical characteristics and laboratory findings of patients with COVID-19 in Rasht, Iran. J Curr Biomed Reports. 2022;3(2):91-7. [DOI:10.52547/JCBioR.3.2.91]
8. Nagarajan R. COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis. Prev Chronic Dis. 2022;19:E53. [DOI:10.5888/pcd19.210228]
9. Bharat A, Machuca TN, Querrey M, Kurihara C, Garza-Castillon R, Kim S, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. 2021;9(5):487-497. [DOI:10.1016/S2213-2600(21)00077-1]
10. Kute VB, Fleetwood VA, Meshram HS, Guenette A, Lentine KL. Use of organs from SARS-CoV-2 infected donors: is it safe? A contemporary review. Curr Transplant Reports. 2021;8(4):281-292. [DOI:10.1007/s40472-021-00343-0]
11. Kute VB, Godara S, Guleria S, Ray DS, Aziz F, Hegde U, et al. Is it safe to be transplanted from living donors who recovered from COVID-19? Experience of 31 kidney transplants in a multicenter cohort study from India. Transplantation. 2021;105(4) :842-850. [DOI:10.1097/TP.0000000000003609]
12. Güner HR, Hasanoğlu İ, Aktaş F. COVID-19: Prevention and control measures in community. Turkish J Med Sci. 2020;50(9):571-577. [DOI:10.3906/sag-2004-146]
13. Ashraf S, Roodsari NN, Zeinali T, Faraji N, Ziabari SMZ. Health protocol compliance in the prevention of COVID-19: Comparison of healthcare workers and ordinary people groups. J Curr Biomed Reports. 2022;3(3):150-157.
14. Wang X, Pan Z, Cheng Z. Association between 2019-nCoV transmission and N95 respirator use. J Hosp Infect. 2020;105(1):104-105. [DOI:10.1016/j.jhin.2020.02.021]
15. Raveh Y, Livingstone J, Vianna R, Nicolau-Raducu R. Personal Protective Equipment for Liver Transplant in SARS-CoV-2 Polymerase Chain Reaction-Positive Convalescing Recipients. Transplant Proc. 2022;54(6):1528-1533. [DOI:10.1016/j.transproceed.2022.05.014]
16. Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74(1):148-155. [DOI:10.1016/j.jhep.2020.07.040]
17. Lippi G, De Oliveira MHS, Henry BM. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis. Eur J Gastroenterol Hepatol. 2021;33(1):114-115. [DOI:10.1097/MEG.0000000000001742]
18. Kulkarni A V, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, et al. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine. 2021;38:101025. [DOI:10.1016/j.eclinm.2021.101025]
19. Nickerson AM, Sobotka LA, Kelly SG. PRO: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should Undergo Liver Transplantation. Clin Liver Dis. 2021;18(5):230-232. [DOI:10.1002/cld.1131]
20. Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, et al. Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study. Clin Gastroenterol Hepatol. 2021;19(7):1469-1479. [DOI:10.1016/j.cgh.2020.09.027]
21. Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology. 2020;159(2):768-771. [DOI:10.1053/j.gastro.2020.04.064]
22. Xu L, Ying S, Hu J, Wang Y, Yang M, Ge T, et al. Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models. Respir Res. 2018;19(1):242. [DOI:10.1186/s12931-018-0934-5]
23. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385-1396.z [DOI:10.1016/j.jhep.2014.08.010]
24. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. [DOI:10.1016/S0140-6736(20)30154-9]
25. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis. 2020;221(11):1757-1561. [DOI:10.1093/infdis/jiaa077]
26. Li W, Zhang B, Lu J, Liu S, Chang Z, Peng C, et al. Characteristics of household transmission of COVID-19. Clin Infect Dis. 2020;71(8):1943-1946. [DOI:10.1093/cid/ciaa450]
27. Kazlauskaitė K. Lietuvos sveikatos mokslų universiteto studentų požiūris ir žinios apie COVID-19 bei taikomos infekcijos prevencijos ir kontrolės priemonės. 2021.
28. Reuken PA, Rauchfuss F, Albers S, Settmacher U, Trautwein C, Bruns T, et al. Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic. Am J Transplant. 2020;20(11):3042-3050. [DOI:10.1111/ajt.16118]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC
